Skip to main content
Premium Trial:

Request an Annual Quote

Clinical MicroArrays Closes $7.5 Million Series A Financing

NEW YORK, Oct. 21 (GenomeWeb News) - Clinical MicroArrays of Natick, Mass., on Thursday closed on a $7.5 million Series A financing led by Oxford Bioscience Partners.


Other investors include the Boston private equity firms of Rock Maple Ventures and Fletcher Spaght Venture Partners, as well as individual investors led by Jean "Coco" Montagu, chairman of the Clinical MicroArrays, and the founder of Genetic Microsystems, and later vice president of advanced technology at Affymetrix.


Clinical MicroArrays will use the funds to accelerate its development efforts with a goal of product commercialization in 2005, the company said in a statement.


The company is developing the MultiMark Express System, a technology platform consisting of protein surface chemistry for biochips, image detection, and sample processing for automating the analysis of disease-specific biomarker panels.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.